Inventor · disambiguated record
Robin Barbour
Also filed as: BARBOUR ROBIN · BARBOUR ROBIN M · BARBOUR ROBIN MCDAID
50 granted patents·30 pending applications·557 citations·filing 1992–2025
98Inventor score
Files withPROTHENA BIOSCIENCES LTD38OTHAIR PROTHENA LTD15ELAN PHARM INC7BIOGEN MA INC4NEOTOPE BIOSCIENCES LTD3
Top patents by PatentIndex Score
80 records- 0198US7910333B2Antibodies to alpha-synucleinELAN PHARM INC·Filed 2010·Granted Mar 22, 2011·52 cites·9 claims
- 0297US10961302B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Mar 30, 2021·7 cites·38 claims
- 0396US11440953B2Anti-abeta antibodiesOTHAIR PROTHENA LTD·Filed 2022·Granted Sep 13, 2022·3 cites·19 claims
- 0496US11434283B2Anti-abeta antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Sep 6, 2022·3 cites·19 claims
- 0596US10752679B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Aug 25, 2020·11 cites·30 claims
- 0696US10501531B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Dec 10, 2019·16 cites·26 claims
- 0796US7674599B2Methods of using antibodies to detect alpha-synuclein in fluid samplesELAN PHARM INC·Filed 2004·Granted Mar 9, 2010·49 cites·11 claims
- 0895US11965005B2Multi-epitope vaccine for the treatment of Alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2023·Granted Apr 23, 2024·1 cites·25 claims
- 0995US11434285B2Anti-Abeta antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Sep 6, 2022·2 cites·19 claims
- 1095US11434284B2Anti-Abeta antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Sep 6, 2022·2 cites·19 claims
- 1195US10889638B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Jan 12, 2021·12 cites·196 claims
- 1295US6114133AMethods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)ELAN PHARM INC·Filed 1994·Granted Sep 5, 2000·187 cites·20 claims
- 1394US12195525B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2022·Granted Jan 14, 2025·1 cites·20 claims
- 1493US12479910B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2024·Granted Nov 25, 2025·1 cites·21 claims
- 1593US10906964B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Feb 2, 2021·7 cites·65 claims
- 1693US10081674B2Antibodies recognizing α-synucleinPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Sep 25, 2018·18 cites·26 claims
- 1793US9605056B2Antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2013·Granted Mar 28, 2017·22 cites·22 claims
- 1892US11492393B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Nov 8, 2022·2 cites·14 claims
- 1992US10301382B2Antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2018·Granted May 28, 2019·10 cites·20 claims
- 2091US8673593B2Antibodies to alpha-synucleinCHILCOTE TAMIE·Filed 2011·Granted Mar 18, 2014·14 cites·8 claims
- 2190US12247056B2Multi-epitope vaccine for the treatment of Alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2024·Granted Mar 11, 2025·0 cites·26 claims
- 2290US10875910B2Antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Dec 29, 2020·2 cites·12 claims
- 2390US2025179161A1Anti-Abeta AntibodiesOTHAIR PROTHENA LTD·Filed 2024·Application pending·0 cites
- 2489US10669331B2Antibodies recognizing α-synucleinPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Jun 2, 2020·3 cites·22 claims
- 2589US10059761B2Anti-Laminin4 antibodies specific for LG4-5PROTHENA BIOSCIENCES LTD·Filed 2015·Granted Aug 28, 2018·8 cites·37 claims
- 2688US11926659B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2021·Granted Mar 12, 2024·1 cites·32 claims
- 2787US11952406B2Multi-epitope vaccine for the treatment of Alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2023·Granted Apr 9, 2024·0 cites·25 claims
- 2887US11945849B2Multi-epitope vaccine for the treatment of Alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2023·Granted Apr 2, 2024·0 cites·25 claims
- 2987US10705095B2Methods and products for evaluating an immune response to a therapeutic proteinBIOGEN MA INC·Filed 2017·Granted Jul 7, 2020·2 cites·22 claims
- 3087US8124350B2Methods and products for evaluating an immune response to a therapeutic proteinSUBRAMANYAM MEENA·Filed 2006·Granted Feb 28, 2012·11 cites·16 claims
- 3186US11584791B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Feb 21, 2023·1 cites·17 claims
- 3286US9709575B2Methods and products for evaluating an immune response to a therapeutic proteinBIOGEN MA INC·Filed 2014·Granted Jul 18, 2017·7 cites·16 claims
- 3385US8871449B2Methods and products for evaluating an immune response to a therapeutic proteinSUBRAMANYAM MEENA·Filed 2011·Granted Oct 28, 2014·8 cites·28 claims
- 3485US2025020660A1Methods and products for evaluating an immune response to a therapeutic proteinBIOGEN MA INC·Filed 2024·Application pending·0 cites
- 3583US6287793B1Diagnostic methods for alzheimer's diseaseELAN PHARM INC·Filed 1992·Granted Sep 11, 2001·62 cites·29 claims
- 3682US2023331828A1Anti-Abeta AntibodiesOTHAIR PROTHENA LTD·Filed 2022·Application pending·0 cites
- 3780US2025282838A1Multi-Epitope Vaccine for the Treatment of Alzheimer's DiseaseOTHAIR PROTHENA LTD·Filed 2025·Application pending·0 cites
- 3879US11267877B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Mar 8, 2022·1 cites·40 claims
- 3979US10654920B2Anti-laminin4 antibodies specific for LG4-5PROTHENA BIOSCIENCES LTD·Filed 2018·Granted May 19, 2020·1 cites·10 claims
- 4079US2024209073A1Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 4178US11958896B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Apr 16, 2024·1 cites·22 claims
- 4278US8741298B2APOE immunotherapySCHENK DALE B·Filed 2012·Granted Jun 3, 2014·3 cites·65 claims
- 4378US2023340094A1Tau ImmunotherapyPROTHENA BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 4477US12435129B2Anti-Aβ antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Oct 7, 2025·0 cites·14 claims
- 4577US7811769B2Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tauELAN PHARM INC·Filed 2004·Granted Oct 12, 2010·2 cites·5 claims
- 4677US7427392B1Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tauELAN PHARM INC·Filed 1995·Granted Sep 23, 2008·22 cites·8 claims
- 4776US2023250161A1Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 4876US2023183304A1Multi-Epitope Vaccine for the Treatment of Alzheimer's DiseaseBARBOUR ROBINOO·Filed 2021·Application pending·0 cites
- 4973US7700309B2Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X->41) and tauELAN PHARM INC·Filed 2004·Granted Apr 20, 2010·1 cites·18 claims
- 5072US11686734B2Methods and products for evaluating an immune response to a therapeutic proteinBIOGEN MA INC·Filed 2020·Granted Jun 27, 2023·0 cites·11 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robin Barbour files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →